Fig. 5From: Insilico design, ADMET screening, MM-GBSA binding free energy of novel 1,3,4 oxadiazoles linked Schiff bases as PARP-1 inhibitors targeting breast cancerLigand interaction of Standard Tamoxifen and Olaparib with PARP-1 5DS3Back to article page